Mumps: Previous page | 1,2,3,4

Key Points and Vaccine Summary

Table of contents for Mumps Introduction Mumps - The Disease Mumps - The vaccine Key Points and Vaccine Summary

Key Points

• Mumps is transmitted in airborne droplets when infected people/children cough and sneeze.
• About a third of people/children infected with mumps have no symptoms.
• The most common symptom — if symptoms do develop — is swelling in the salivary glands.
• Complications from mumps can be serious, but they are rare.
• Mumps vaccine should be given in combination with measles and rubella vaccines (MMR).

Vaccine Summary

• Type of vaccine Live attenuated viral
• Number of doses One dose
• Schedule Generally 12–15 months
• Booster A second opportunity for immunization is recommended ( routine or campaign )
• Contraindications Severe reaction to previous dose; pregnancy; congenital or acquired immune disorders (not HIV infection). Although it is not recommended to administer the vaccine during pregnancy, there has never been any evidence of damage to the fetus from vaccinating the mother during pregnancy
• Adverse reactions Same as measles vaccine, plus cases of arthritis in adolescent females for rubella-containing vaccine and parotitis; rarely aseptic meningitis with mumps- containing vaccines may occur
• Special precautions None
• Dosage 0.5ml
  Injection site Outer mid-thigh/upper arm depending on the age
• Injection type Subcutaneous
• Storage Store between 2°C–8°C(vaccine maybe frozen for long-term storage but not the diluent)

Mumps: 1,2,3,4